2015 Q3 Form 10-Q Financial Statement

#000091060615000030 Filed on August 06, 2015

View on sec.gov

Income Statement

Concept 2015 Q3
Revenue $142.1M
YoY Change 6.36%
Cost Of Revenue $35.80M
YoY Change 8.48%
Gross Profit $106.3M
YoY Change 5.67%
Gross Profit Margin 74.81%
Selling, General & Admin $14.80M
YoY Change 2.07%
% of Gross Profit 13.92%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $37.00M
YoY Change 1.37%
% of Gross Profit 34.81%
Operating Expenses $53.70M
YoY Change 1.51%
Operating Profit $52.60M
YoY Change 10.27%
Interest Expense -$20.60M
YoY Change -5.5%
% of Operating Profit -39.16%
Other Income/Expense, Net
YoY Change
Pretax Income $32.00M
YoY Change 23.55%
Income Tax
% Of Pretax Income
Net Earnings $31.20M
YoY Change 21.4%
Net Earnings / Revenue 21.96%
Basic Earnings Per Share $0.57
Diluted Earnings Per Share $0.57
COMMON SHARES
Basic Shares Outstanding 94.16M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $24.00M
YoY Change -76.24%
Cash & Equivalents $24.00M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $25.00M
Other Receivables $61.00M
Total Short-Term Assets $110.0M
YoY Change -43.3%
LONG-TERM ASSETS
Property, Plant & Equipment $3.484B
YoY Change 2.74%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $349.0M
YoY Change -1.97%
Other Assets $83.00M
YoY Change 1.22%
Total Long-Term Assets $4.061B
YoY Change 3.23%
TOTAL ASSETS
Total Short-Term Assets $110.0M
Total Long-Term Assets $4.061B
Total Assets $4.171B
YoY Change 1.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $171.0M
YoY Change -1.72%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $196.0M
YoY Change -1.51%
LONG-TERM LIABILITIES
Long-Term Debt $2.024B
YoY Change 0.05%
Other Long-Term Liabilities $43.00M
YoY Change 34.38%
Total Long-Term Liabilities $2.067B
YoY Change 0.58%
TOTAL LIABILITIES
Total Short-Term Liabilities $196.0M
Total Long-Term Liabilities $2.067B
Total Liabilities $2.292B
YoY Change 0.39%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.879B
YoY Change
Total Liabilities & Shareholders Equity $4.171B
YoY Change 1.04%

Cashflow Statement

Concept 2015 Q3
OPERATING ACTIVITIES
Net Income $31.20M
YoY Change 21.4%
Depreciation, Depletion And Amortization $37.00M
YoY Change 1.37%
Cash From Operating Activities $89.40M
YoY Change -8.96%
INVESTING ACTIVITIES
Capital Expenditures -$102.1M
YoY Change 17.22%
Acquisitions
YoY Change
Other Investing Activities $70.40M
YoY Change 11.04%
Cash From Investing Activities -$31.70M
YoY Change 33.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -60.90M
YoY Change 474.53%
NET CHANGE
Cash From Operating Activities 89.40M
Cash From Investing Activities -31.70M
Cash From Financing Activities -60.90M
Net Change In Cash -3.200M
YoY Change -105.01%
FREE CASH FLOW
Cash From Operating Activities $89.40M
Capital Expenditures -$102.1M
Free Cash Flow $191.5M
YoY Change 3.35%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
reg Equity Offering Net Proceeds
EquityOfferingNetProceeds
193800000 USD
CY2015Q2 reg Letters Of Credit Maximum Borrowing Capacity Under Line
LettersOfCreditMaximumBorrowingCapacityUnderLine
50000000 USD
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
REGENCY CENTERS CORP
dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2014Q4 reg Total Longterm Debtand Lineof Credits
TotalLongtermDebtandLineofCredits
2021357000 USD
dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2015Q2 reg Total Longterm Debtand Lineof Credits
TotalLongtermDebtandLineofCredits
1988700000 USD
CY2014Q2 reg Acquired Finite Lived Intangible Liability Amount
AcquiredFiniteLivedIntangibleLiabilityAmount
5892000 USD
reg Weighted Average Price Per Share
WeightedAveragePricePerShare
64.72
CY2015Q2 reg Availableforsale Securities Equity Debt Maturities Next Rolling Twelve Months Fair Value
AvailableforsaleSecuritiesEquityDebtMaturitiesNextRollingTwelveMonthsFairValue
2208000 USD
CY2015Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Document Period End Date
DocumentPeriodEndDate
2015-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000910606
CY2015Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
94156976 shares
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2015Q2 reg Availableforsale Securities Equity Debt Maturities Rolling After Year Three Fair Value
AvailableforsaleSecuritiesEquityDebtMaturitiesRollingAfterYearThreeFairValue
1521000 USD
CY2015Q2 reg Availableforsale Securities Equity Debt Maturities Rolling Year One Through Three Fair Value
AvailableforsaleSecuritiesEquityDebtMaturitiesRollingYearOneThroughThreeFairValue
4171000 USD
CY2014Q2 reg Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Debt Assumed Netof Premiums
BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebtAssumedNetofPremiums
78049000 USD
CY2015Q2 reg Equity Issuances Amount Available For Issuance
EquityIssuancesAmountAvailableForIssuance
95000000 USD
CY2015Q1 reg Equity Offering Common Sharesavailableforissue
EquityOfferingCommonSharesavailableforissue
2875000 shares
CY2015Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
-31000 USD
CY2015Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
7930000 USD
us-gaap Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months
CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
-8500000 USD
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.94
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.97
CY2014Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
27600000 USD
CY2015Q2 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
29000000 USD
CY2014Q2 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-2318000 USD
us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-4837000 USD
CY2015Q2 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-2250000 USD
us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-4500000 USD
CY2014Q2 us-gaap Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net
DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
0 USD
us-gaap Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net
DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
0 USD
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
6460000 USD
CY2014Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
5900000 USD
CY2015Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
5900000 USD
us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2019-05-13
CY2014Q4 us-gaap Notes Payable
NotesPayable
1946357000 USD
CY2015Q2 us-gaap Notes Payable
NotesPayable
1868700000 USD
CY2014Q4 us-gaap Notes Receivable Net
NotesReceivableNet
12132000 USD
CY2015Q2 us-gaap Notes Receivable Net
NotesReceivableNet
12281000 USD
us-gaap Operations Commenced Date1
OperationsCommencedDate1
1993-12-31
CY2014Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-11153000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-24953000 USD
CY2015Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
18376000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
4494000 USD
us-gaap Payments For Commissions
PaymentsForCommissions
15000 USD
us-gaap Weighted Average Limited Partnership Units Outstanding
WeightedAverageLimitedPartnershipUnitsOutstanding
154170 shares
CY2015Q2 us-gaap Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net
DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
0 USD
us-gaap Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net
DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
0 USD
us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
14979000 USD
CY2014Q2 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
1691000 USD
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
2406000 USD
CY2015Q2 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
5657000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
189386000 USD
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
0 USD
us-gaap Proceeds From Deposits On Real Estate Sales
ProceedsFromDepositsOnRealEstateSales
4500000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1173000 USD
CY2014Q2 us-gaap Proceeds From Sale Of Real Estate
ProceedsFromSaleOfRealEstate
2747000 USD
us-gaap Proceeds From Sale Of Real Estate
ProceedsFromSaleOfRealEstate
7219000 USD
CY2015Q2 us-gaap Proceeds From Sale Of Real Estate
ProceedsFromSaleOfRealEstate
22968000 USD
us-gaap Proceeds From Sale Of Real Estate
ProceedsFromSaleOfRealEstate
26382000 USD
CY2014Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0 shares
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
18000 shares
CY2014Q4 us-gaap Unsecured Debt
UnsecuredDebt
75000000 USD
CY2015Q2 us-gaap Unsecured Debt
UnsecuredDebt
120000000 USD
CY2014Q2 us-gaap Weighted Average Limited Partnership Units Outstanding
WeightedAverageLimitedPartnershipUnitsOutstanding
159338 shares
us-gaap Weighted Average Limited Partnership Units Outstanding
WeightedAverageLimitedPartnershipUnitsOutstanding
159804 shares
CY2015Q2 us-gaap Weighted Average Limited Partnership Units Outstanding
WeightedAverageLimitedPartnershipUnitsOutstanding
154170000 shares

Files In Submission

Name View Source Status
0000910606-15-000030-index-headers.html Edgar Link pending
0000910606-15-000030-index.html Edgar Link pending
0000910606-15-000030.txt Edgar Link pending
0000910606-15-000030-xbrl.zip Edgar Link pending
ex-311063015.htm Edgar Link pending
ex-312063015.htm Edgar Link pending
ex-313063015.htm Edgar Link pending
ex-314063015.htm Edgar Link pending
ex-321063015.htm Edgar Link pending
ex-322063015.htm Edgar Link pending
ex-323063015.htm Edgar Link pending
ex-324063015.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
reg-20150630.xml Edgar Link completed
reg-20150630.xsd Edgar Link pending
reg-20150630_cal.xml Edgar Link unprocessable
reg-20150630_def.xml Edgar Link unprocessable
reg-20150630_lab.xml Edgar Link unprocessable
reg-20150630_pre.xml Edgar Link unprocessable
reg10-q063015.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending